`
`PTO/AIA/15 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number
`
`UTILITY
`PATENT APPLICATION
`TRANSMITTAL
`
`Attorney Docket No.
`
`First Named Inventor
`
`Title
`
`10-1188-US-CON3
`Robert Frederick Veasey
`Pen-Type Injector
`
`>
`
`(Only for new nonprovisional applications under 37 CFR 1.53(b))
`
`Express Mail Label No.
`
`J
`
`APPLICATION ELEMENTS
`See MPEP chapter 600 concerning utility patent application contents.
`
`1.
`
`2.
`
`3.
`
`8.
`
`Fee Transmittal Form
`(PTO/SB/17 or equivalent)
`Applicant asserts small entity status.
`See 37 CFR 1.27
`Applicant certifies micro entity status. See 37 CFR 1.29.
`Applicant must attach form PTO/SB/15A or B or equivalent.
`18
`4. [^] Specification
`[Total Pages
`Both the claims and abstract must start on a new page.
`(See MPEP § 608.01(a) for information on the preferred arrangement)
`5.1 ^ I Drawing(s) (35 U.S.C. 113)
`[Total Sheets
`]
`6. Inventor's Oath or Declaration
`[Total Pages
`]
`(including substitute statements under 37 CFR 1.64 and assignments
`serving as an oath or declaration under 37 CFR 1.63(e))
`a. |^] Newly executed (original or copy)
`b.
`A copy from a prior application (37 CFR 1.63(d))
`7. |
`| Application Data Sheet
`* See note below.
`See 37 CFR 1.76 (PTO/AIA/14 or equivalent)
`CD-ROM or CD-R
`in duplicate, large table, or Computer Program (Appendix)
`| Landscape Table on CD
`|
`9. Nucleotide and/or Amino Acid Sequence Submission
`(if applicable, items a. - c. are required)
`a. |
`| Computer Readable Form (CRF)
`b.|
`| Specification Sequence Listing on:
`i. |^| CD-ROM or CD-R (2 copies); or
`ii. |
`| Paper
`Statements verifying identity of above copies
`
`c.
`
`ADDRESS TO:
`
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`ACCOMPANYING APPLICATION PAPERS
`Assignment Papers
`(cover sheet & document(s))
`Name of Assignee
`
`10.
`
`|
`
`| Power of Attorney
`
`12.
`
`15.
`
`16.
`
`17.
`
`11. Q 37 CFR 3.73(c) Statement
`(when there is an assignee)
`English Translation Document
`[if applicable)
`13. [^] Information Disclosure Statement
`(PTO/SB/OS or PTO-1449)
`| ^ | Copies of citations attached
`14. [^] Preliminary Amendment
`Return Receipt Postcard
`(MPEP § 503) (Should be specifically itemized)
`Certified Copy of Priority Document(s)
`[if foreign priority is claimed)
`Nonpublication Request
`Under 35 U.S.C. 122(b)(2)(B)(i). Applicant must attach form PTO/SB/35
`or equivalent.
`18 | ^ | Other* Certtfication anc' Fiequest for Prioritized Examination Form (Trackl)
`General Authorization
`
`*Note: (1) Benefit claims under 37 CFR 1.78 and foreign priority claims under 1.55 must be included in an Application Data Sheet (ADS).
`(2) For applications filed under 35 U.S.C. Ill, the application must contain an ADS specifying the applicant if the applicant is an
`assignee, person to whom the inventor is under an obligation to assign, or person who otherwise shows sufficient proprietary
`interest in the matter. See 37 CFR 1.46(b).
`19. CORRESPONDENCE ADDRESS
`
`| ^ | The address associated with Customer Number:
`
`20306
`
`OR
`
`Correspondence address below
`
`Name
`
`Address
`
`City
`
`State
`
`Country
`Telephone
`T
`/Thomas E. Wettermann/
`Signature
`Name
`L (Print/Type) Thomas E. Wettermann
`
`Zip Code
`
`
`Date
`
`June 4, 2013
`41,523
`
`Registration No.
`(Attorney/Agent)
`This collection of information is required by 37 CFR 1.53(b). The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
`to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to complete,
`including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on
`the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND
`TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`//you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1007, p. 1 of 256
`
`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your
`submission of the attached form related to a patent application or patent. Accordingly, pursuant to the
`requirements of the Act, please be advised that: (1) the general authority for the collection of this information is
`35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which
`the information is used by the U.S. Patent and Trademark Office is to process and/or examine your submission
`related to a patent application or patent. If you do not furnish the requested information, the U.S. Patent and
`Trademark Office may not be able to process and/or examine your submission, which may result in termination
`of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of
`records may be disclosed to the Department of Justice to determine whether disclosure of these
`records is required by the Freedom of Information Act.
`A record from this system of records may be disclosed, as a routine use, in the course of presenting
`evidence to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in
`the course of settlement negotiations.
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress
`submitting a request involving an individual, to whom the record pertains, when the individual has
`requested assistance from the Member with respect to the subject matter of the record.
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency
`having need for the information in order to perform a contract. Recipients of information shall be
`required to comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C.
`552a(m).
`A record related to an International Application filed under the Patent Cooperation Treaty in this
`system of records may be disclosed, as a routine use, to the International Bureau of the World
`Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`A record in this system of records may be disclosed, as a routine use, to another federal agency for
`purposes of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act
`(42 U.S.C. 218(c)).
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General
`Services, or his/her designee, during an inspection of records conducted by GSA as part of that
`agency's responsibility to recommend improvements in records management practices and programs,
`under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or
`Commerce) directive. Such disclosure shall not be used to make determinations about individuals.
`A record from this system of records may be disclosed, as a routine use, to the public after either
`publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35
`U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine
`use, to the public if the record was filed in an application which became abandoned or in which the
`proceedings were terminated and which application is referenced by either a published application, an
`application open to public inspection or an issued patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local
`law enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or
`regulation.
`
`3.
`
`4
`
`5.
`
`Q
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1007, p. 2 of 256
`
`
`
`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`10-1188-US-CON3
`
`Application Number
`
`Title of Invention
`
`Pen-Type Injector
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`Secrecy Order 37 CFR 5.2
`Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`EH 37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`Inventor Information:
`
`Inventor 1
`Legal Name
`
`Remove
`
`Family Name
`Prefix Given Name
`Middle Name
`Veasey
`Robert
`Frederick
`Residence Information (Select One) Q US Residency
`(•) Non US Residency 0 Active US Military Service
`City
`Country of Residence i
`Warwickshire
`
`GB
`
`Suffix
`
`Mailing Address of Inventor:
`
`31 Lonsdale Road
`Leamington Spa
`
`Warwickshire
`
`CV327EP
`
`State/Province
`Country i
`GB
`
`Address 1
`Address 2
`City
`Postal Code
`
`2
`Inventor
`Legal Name
`
`Remove
`
`Family Name
`Prefix Given Name
`Perkins
`Robert
`Residence Information (Select One) Q US Residency
`(•) Non US Residency 0 Active US Military Service
`City
`Country of Residence i
`Oxfordshire
`
`Middle Name
`
`GB
`
`Suffix
`
`Mailing Address of Inventor:
`
`Address 1
`Address 2
`City
`Postal Code
`
`6 Printers Court Abingdon
`
`Oxfordshire
`
`OX14 SBZ
`
`State/Province
`Country i
`GB
`
`Inventor 3
`Legal Name
`
`EFS Web 2.2.6
`
`Remove
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1007, p. 3 of 256
`
`
`
`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`10-1188-US-CON3
`
`Application Number
`
`Title of Invention
`
`Pen-Type Injector
`
`Family Name
`Middle Name
`Prefix Given Name
`Aubrey
`Plumptre
`David
`Residence Information (Select One) Q US Residency
`(•) Non US Residency 0 Active US Military Service
`City
`Country of Residence i
`Worcestershire
`
`GB
`
`Suffix
`
`Mailing Address of Inventor:
`
`36 Shire Way
`Address 1
`Address 2
`Droitwich
`State/Province
`City
`Worcestershire
`Country i
`Postal Code
`WR97
`GB
`All Inventors Must Be Listed - Additional Inventor Information blocks may be
`generated within this form by selecting the Add button.
`
`Add
`
`Correspondence Information:
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`
`Q An Address is being provided for the correspondence Information of this application.
`
`Customer Number
`Email Address
`
`20306
`
`docketing@mbhb.com
`
`Application Information:
`Pen-Type Injector
`Title of the Invention
`Attorney Docket Number 10-1188-US-CON3
`Application Type
`Nonprovisional
`Subject Matter
`
`Utility
`
`Add Email
`
`Remove Email
`
`Small Entity Status Claimed Q
`
`7
`
`Suggested Figure for Publication (if any)
`
`Total Number of Drawing Sheets (if any)
`Publication Information:
`• Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`R6C|U6St Not to Publish. I hereby request that the attached application not be published under
`Q 35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months after filing.
`
`Representative Information:
`
`EFS Web 2.2.6
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1007, p. 4 of 256
`
`
`
`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`10-1188-US-CON3
`
`Application Number
`
`Title of Invention
`
`Pen-Type Injector
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below. If both sections are completed the customer
`Number will be used for the Representative Information during processing.
`
`Please Select One:
`
`Customer Number
`
`(•) Customer Number O US Patent Practitioner O Limited Recognition (37 CFR 11.9)
`20306
`
`Domestic Benefit/National Stage Information:
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 365(c) or indicate
`National Stage entry from a PCT application. Providing this information in the application data sheet constitutes the
`specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`Prior Application Status Pending
`
`Remove
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Continuation of
`
`12/944544
`
`2010-11-11
`
`Remove
`
`Prior Application Status Patented
`Application
`Number
`12/944544
`
`Continuation of
`
`Continuity Type
`
`Prior Application
`Number
`11/483546
`
`Filing Date
`(YYYY-MM-DD)
`2006-07-11
`
`Patent Number
`
`Issue Date
`(YYYY-MM-DD)
`
`7918833
`
`2011-04-05
`
`Prior Application Status Abandoned
`
`Remove
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`11/483546
`
`Continuation of
`
`10790225
`
`2004-03-02
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`Foreign Priority Information:
`
`Add
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`constitutes the claim for priority as required by 35 U.S.C. 119(b) and 37 CFR 1.55(d). When priority is claimed to a foreign application
`that is eligible for retrieval under the priority document exchange program (PDX) 'the information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1.55(h)(1) and (2). Under the PDX program, applicant bears the ultimate
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`property office, or a certified copy of the foreign priority application is filed, within the time period specified in 37 CFR 1.55(g)(1).
`
`Application Number
`
`Country
`
`Filing Date (YYYY-MM-DD)
`
`Access Code (if applicable)
`
`2003-03-03
`GB
`0304822.0
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`Add
`
`Remove
`
`EFS Web 2.2.6
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1007, p. 5 of 256
`
`
`
`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`10-1188-US-CON3
`
`Application Number
`
`Title of Invention
`
`Pen-Type Injector
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition
`Applications
`
`This application (1) claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`Q contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March
`16, 2013.
`
`Authorization to Permit Access:
`[x] Authorization to Permit Access to the Instant Application by the Participating Offices
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO),
`the Japan Patent Office (JPO), the Korean Intellectual Property Office (KIPO), the World Intellectual Property Office (WIPO),
`and any other intellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed access to the instant patent application. See 37 CFR 1.14(c) and (h). This box should not be checked if the applicant
`does not wish the EPO, JPO, KIPO, WIPO, or other intellectual property office in which a foreign application claiming priority
`to the instant patent application is filed to have access to the instant patent application.
`
`In accordance with 37 CFR 1.14(h)(3), access will be provided to a copy of the instant patent application with respect
`to: 1) the instant patent application-as-filed; 2) any foreign application to which the instant patent application
`claims priority under 35 U.S.C. 119(a)-(d) if a copy of the foreign application that satisfies the certified copy requirement of
`37 CFR 1.55 has been filed in the instant patent application; and 3) any U.S. application-as-filed from which benefit is
`sought in the instant patent application.
`
`In accordance with 37 CFR 1.14(c), access may be provided to information concerning the date of filing this Authorization.
`
`Applicant Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 of Title 37 of CFR
`to have an assignment recorded by the Office.
`
`Remove
`Applicant 1
`If the applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`1.43; or the name and address of the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`who otherwise shows sufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise shows sufficient
`proprietary interest) together with one or more joint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`i
`.
`
`Clear
`
`Q Assignee
`
`0 Legal Representative under 35 U.S.C. 117
`
`0 Joint Inventor
`
`0 Person to whom the inventor is obligated to assign.
`
`0 Person who shows sufficient proprietary interest
`
`EFS Web 2.2.6
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1007, p. 6 of 256
`
`
`
`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`10-1188-US-CON3
`
`Application Number
`
`Title of Invention
`
`Pen-Type Injector
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`Name of the Deceased or Legally Incapacitated Inventor:
`
`If the Applicant is an Organization check here. Q
`
`Prefix
`
`Given Name
`
`Middle Name
`
`Family Name
`
`Suffix
`
`Mailing Address Information:
`Address 1
`
`Address 2
`City
`Country '
`
`Phone Number
`
`Email Address
`
`State/Province
`
`Postal Code
`
`Fax Number
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`Add
`
`Non-Applicant Assignee Information:
`
`Providing assignment information in this section does not subsitute for compliance with any requirement of part 3 of Title 37 of CFR to
`have an assignment recorded by the Office.
`
`Assignee 1
`
`Complete this section only if non-applicant assignee information is desired to be included on the patent application publication in
`accordance with 37 CFR 1.215(b). Do not include in this section an applicant under 37 CFR 1.46 (assignee, person to whom the
`inventor is obligated to assign, or person who otherwise shows sufficient proprietary interest), as the patent application publication will
`include the name of the applicant(s).
`
`| Remove""|
`
`If the Assignee is an Organization check here.
`
`Organization Name
`
`DCA Design International LTD
`
`EFS Web 2.2.6
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1007, p. 7 of 256
`
`
`
`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`10-1188-US-CON3
`
`Application Number
`
`Title of Invention
`
`Pen-Type Injector
`
`Mailing Address Information:
`
`19 Church Street
`
`Warwick
`
`Address 1
`
`Address 2
`
`City
`Country i
`
`GB
`
`Phone Number
`
`Email Address
`
`State/Province
`Postal Code
`
`Fax Number
`
`CV34 4AB
`
`Additional Assignee Data may be generated within this form by selecting the Add button.
`
`Add
`
`Signature:
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`certifications
`
`Remove
`
`Signature
`
`/Thomas E. Wettermann/
`
`Date (YYYY-MM-DD)
`
`2013-06-04
`
`First Name
`
`Thomas E.
`
`Last Name
`
`Wettermann
`
`Registration Number
`
`41523
`
`Additional Signature may be generated within this form by selecting the Add button.
`
`Add
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.6
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1007, p. 8 of 256
`
`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent. If you do not
`furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom of Information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee,
`during an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuant
`to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`USPTO becomes aware of a violation or potential violation of law or regulation.
`
`5.
`
`6.
`
`8.
`
`g
`
`EFS Web 2.2.6
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1007, p. 9 of 256
`
`
`
`PEN-TYPE INJECTOR
`
`CROSS REFERENCE TO RELATED APPLICATIONS
`
`The present application is a continuation application of U.S. Patent Application No.
`
`12/944,544, filed November 11 2010, entitled "Pen-Type Injector", which is a
`
`5
`
`continuation application of U.S. Patent Application No. 11/483,546, filed July 11, 2006
`
`now U.S. Patent No. 7,918,833, which is a continuation application of U.S. Patent
`
`Application No. 10/790,225, filed March 2, 2004, abandoned, and claims priority to GB
`
`Patent Application No. 0304822.0, filed March 3, 2003, the entire contents of each of
`
`which are incorporated herein by reference.
`
`10
`
`15
`
`20
`
`BACKGROUND
`
`Improvements in and relating to a pen-type injector
`
`The present invention relates to pen-type injectors, that is to injectors of the kind that
`provide for administration by injection of medicinal products from a multidose cartridge.
`In particular, the present invention relates to such injectors where a user may set the
`dose.
`
`Such injectors have application where regular injection by persons without formal
`medical training occurs. This is increasingly common amongst those having diabetes
`where self-treatment enables such persons to conduct effective management of their
`diabetes.
`
`These circumstances set a number of requirements for pen-type injectors of this kind.
`The injector must be robust in construction, yet easy to use both in terms of the
`
`25
`
`1
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1007, p. 10 of 256
`
`
`
`manipulation of the parts and understanding by a user of its operation. In the case of
`those with diabetes, many users will be physically infirm and may also have impaired
`vision. Where the injector is to be disposable rather than reusable, the injector should
`be cheap to manufacture and easy to dispose of (preferably being suitable for
`recycling).
`
`OVERVIEW
`It is an advantage of the present invention that an improved pen-type injector is
`provided.
`
`According to a first aspect of the present invention, a pen-type injector comprises a
`housing;
`a piston rod adapted to operate through the housing;
`a dose dial sleeve located between the housing and the piston rod, the dose dial sleeve
`having a helical thread of first lead;
`a drive sleeve located between the dose dial sleeve and the piston rod, the drive sleeve
`having a helical groove of second lead;
`characterized in that the first lead of the helical thread and the second lead of the helical
`groove are the same.
`
`Preferably, the piston rod has a first threaded portion at a first end and a second
`threaded portion at a second end;
`an insert or radially inwardly extending flange is located in the housing and through
`which the first threaded portion of the piston rod may rotate;
`the dose dial sleeve being rotatable with respect to the housing and the insert;
`the drive sleeve being releasably connected to the dose dial sleeve and connected to
`the piston rod for rotation with respect thereto along the second threaded portion of the
`piston rod;
`a button is located on the dose dial sleeve and rotatable with respect to the dose dial
`sleeve; and
`
`5
`
`10
`
`15
`
`20
`
`25
`
`30
`
`2
`
`PFIZER, INC. v. SANOFI-AVENTIS DEUTSCHLAND GMBH
`
`Ex. 1007, p. 11 of 256
`
`
`
`clutch means are provided which upon depression of the button permit rotation between
`the dose dial sleeve and the drive sleeve.
`
`Preferably, the injector further comprises a nut which is rotatable with respect to the
`drive sleeve and axially displaceable but not rotatable with respect to the housing.
`
`5
`
`More preferably, the drive sleeve is provided at a first end with first and second flanges
`with an intermediate thread between the first and second flanges, the nut being
`disposed between the first and second flanges and keyed to the housing by spline
`means. Additionally, a first radial stop may be provided on a second face of the nut and
`a second radial stop may be provided on a first face of the second flange.
`
`Preferably, the first thread of the piston rod is oppositely disposed to the second thread
`of the piston rod.
`
`Preferably, a second end of the clutch is provided with a plurality of dog teeth adapted
`to engage with a second end of the dose dial sleeve.
`
`10
`
`15
`
`Preferably, the pen-type injector further includes clicker means disposed between the
`clutch means and spline means provided on the housing.
`
`20
`
`More preferably, the clicker means comprises a sleeve provided at a first end with a
`helically extending arm, a free end of the arm having a toothed member, and at a
`second end with a plurality of circumferentially directed saw teeth adapted to engage a
`